Tom J Wandless

Title: Tom J Wandless: Innovator in T Cell Therapy

Introduction

Tom J Wandless is a prominent inventor based in Stanford, CA (US). He has made significant contributions to the field of immunology, particularly in the treatment of T cell exhaustion. His innovative work has implications for both clinical and research settings, enhancing our understanding of T cell functionality.

Latest Patents

Tom J Wandless holds a patent titled "Methods of treating T cell exhaustion by inhibiting or modulating T cell receptor signaling." This invention relates to T cell compositions and methods of using them in therapy and treatment. Specifically, it provides chimeric antigen receptor (CAR) T cells that are modified to maintain functionality under conditions where unmodified CAR T cells exhibit exhaustion. The compositions and methods disclosed in this patent are designed to inhibit or reverse CAR T cell exhaustion, thereby enhancing CAR T cell function.

Career Highlights

Wandless is affiliated with Leland Stanford Junior University, where he continues to advance research in immunology and oncology. His work is pivotal in developing therapies that improve the efficacy of CAR T cell treatments. With 1 patent to his name, he is recognized for his innovative approach to tackling challenges in T cell therapy.

Collaborations

Tom J Wandless has collaborated with notable colleagues, including Rachel Lynn and Crystal L Mackall. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in the field.

Conclusion

Tom J Wandless is a key figure in the advancement of T cell therapy, with a focus on overcoming T cell exhaustion. His contributions are vital for the future of immunological treatments and research.